Diatreme Completes Cape Flattery Silica Sale, Unlocking Up To $7.4 Million Funding
Diatreme Resources has finalised the sale of its Cape Flattery Silica Project to a joint venture with Sibelco, receiving $2.1 million in reimbursements and positioning for up to $7.4 million in total funding.
- Sale of Cape Flattery Silica Project to joint venture completed
- Diatreme reimbursed $2.1 million for prior costs
- Sibelco invested $5.1 million with option for $4.4 million more
- Transaction consolidates Far North Queensland silica assets
- Funding boost supports Northern Silica Project development
Joint Venture Deal Finalised for Cape Flattery Silica
Diatreme Resources Limited (ASX:DRX) has wrapped up the sale of its Cape Flattery Silica Project, transferring full ownership of Cape Flattery Silica Pty Ltd to Cape Silica Holdings Pty Ltd, a joint venture between Diatreme and Sibelco Silica Pty Ltd. The deal, originally outlined in April, sees Diatreme receive approximately $2.1 million in reimbursements for costs incurred prior to the sale, alongside an equity stake in the joint venture.
Capital Injection from Sibelco Subscription and Option
Sibelco has subscribed for 435 ordinary shares in the joint venture for about $5.1 million, providing a significant capital injection. Additionally, Sibelco holds a call option exercisable until 7 July 2026 to purchase a further 376 shares for $4.4 million, which would increase total joint venture funding to approximately $7.4 million before costs and stamp duty. This option adds a layer of potential upside to the transaction’s financial impact.
Strategic Streamlining of Far North Queensland Assets
The transaction streamlines Diatreme’s ownership structure across its Far North Queensland silica sand assets. By consolidating project ownership under the joint venture, Diatreme aims to reduce duplication of costs and enhance community engagement efforts. This rationalisation is expected to support the development pathway for its broader strategic critical minerals projects, particularly the flagship Northern Silica Project.
Implications for Northern Silica Project Funding and Development
This sale and joint venture formation mark a pivotal step in Diatreme’s strategy to secure funding and operational synergies. The fresh capital from Sibelco’s subscription and potential option exercise provides a financial boost that could accelerate project milestones. The consolidation also positions Diatreme to focus resources on advancing the Northern Silica Project, which recently saw a 10.6% resource upgrade, underpinning its development potential.
Bottom Line?
Sibelco’s upcoming decision on its call option will be a key catalyst, influencing the scale of funding available to Diatreme’s silica projects and shaping the joint venture’s development trajectory.
Questions in the middle?
- Will Sibelco exercise its $4.4 million call option by early July?
- How will the joint venture structure affect Diatreme’s control over project decisions?
- What impact will the funding boost have on timelines for the Northern Silica Project?
